{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T11:59:06Z","timestamp":1769255946691,"version":"3.49.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"},{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:00:00Z","timestamp":1606348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Onconephrology is a rapidly evolving subspecialty that covers all areas of renal involvement in cancer patients. The complexity of the field may benefit from well-defined multidisciplinary management by a dedicated team. Patients with cancer frequently suffer from concurrent chronic kidney disease (CKD), with a prevalence ranging from 12% to 53% at the time of cancer diagnosis. Taking into account the incidence of cancer and the prevalence of CKD in the Italian population, we estimate that about 44,000 patients suffered from both diseases in 2020. Since there is an increasing necessity to address the needs of this population in dedicated outpatient clinics, it is critical to highlight some basic characteristics and to suggest areas of development. Our experience in the nephrological management of cancer patients clearly suggests the need to implement dedicated multidisciplinary teams and to create onconephrology clinics (at least within larger, referral, hospitals). Furthermore, it must be kept in mind that not only is CKD common in cancer patients, but also that the concomitant presence of these two conditions too often excludes cancer patients from clinical trials, thus limiting their access to therapies that could potentially improve their outcomes. Indeed, the Renal Insufficiency and Cancer Medications (IRMA) study found that cancer patients with CKD or on dialysis are often\u00a0undertreated, or are exposed to either ineffective or toxic anticancer agents. Finally, the aim of this article is to initiate a\u00a0debate about what an onconephrology outpatient clinic might look like, in order to ensure the highest quality of care for this growing patient\u00a0population.<\/jats:p>","DOI":"10.1007\/s40620-020-00922-x","type":"journal-article","created":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T05:02:48Z","timestamp":1606366968000},"page":"1143-1149","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The basics of onco-nephrology in the renal clinic"],"prefix":"10.1093","volume":"33","author":[{"given":"Laura","family":"Cosmai","sequence":"first","affiliation":[{"name":"Nephrology and Dialysis Unit, Onco-Nephrology Outpatient Clinic, ASST Fatebenefratelli-Sacco, Fatebenefratelli Hospital, Piazzale Principessa Clotilde, 320121, Milan, Italy 1"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camillo","family":"Porta","sequence":"additional","affiliation":[{"name":"Chair of Oncology, Department of Biomedical Sciences and Human Oncology, University of Bari \u2018A. Moro, Bari, Italy 2"},{"name":"Policlinico Consorziale di Bari, Bari, Italy 3"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Foramitti","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Dialysis, ASST Cremona, Cremona, Italy 4"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mimma","family":"Rizzo","sequence":"additional","affiliation":[{"name":"Division of Translational Oncology, IRCCS Istituti Clinici Scientifici \u2018Maugeri\u2019, Pavia, Italy 5"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Gallieni","sequence":"additional","affiliation":[{"name":"Nephrology and Dialysis Unit, Onco-Nephrology Outpatient Clinic, ASST Fatebenefratelli-Sacco, Fatebenefratelli Hospital, Piazzale Principessa Clotilde, 320121, Milan, Italy 1"},{"name":"Department of Biomedical and Clinical Sciences \u2018L. Sacco\u2019, University of Milan, Milan, Italy 6"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,26]]},"reference":[{"key":"2026012223573859500_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nrneph.2015.15","article-title":"Renal effects of targeted anticancer therapies","volume":"11","author":"Porta","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"2026012223573859500_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1681\/ASN.2004100843","article-title":"Renal failure associated with cancer and its treatment: an update","volume":"16","author":"Humphreys","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2026012223573859500_CR3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12882-019-1578-5","article-title":"Cancer patterns and association with mortality and renal outcomes in non-dialysis dependent chronic kidney disease: a matched cohort study","volume":"20","author":"Chinnaddurai","year":"2019","journal-title":"BMC Nephrol"},{"key":"2026012223573859500_CR4","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1093\/annonc\/mdv136","article-title":"Renal effects of molecular targeted therapies in Oncology: a review of the Cancer and the Kidney International Network (C-KIN)","volume":"26","author":"Launay-Vacher","year":"2015","journal-title":"Ann Oncol"},{"key":"2026012223573859500_CR5","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21636 32853404","article-title":"Onconephrology: the intersections between the kidney and cancer (2020)","author":"Rosner","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2026012223573859500_CR6","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global cancer incidence and mortality rates and trends\u2014an update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2026012223573859500_CR7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/BF02850082","article-title":"Incidence of renal insufficiency in cancer patients","volume":"22","author":"Dogan","year":"2005","journal-title":"Adv Ther"},{"key":"2026012223573859500_CR8","first-page":"209","article-title":"Incidence of renal insufficiency in cancer patients and evaluation of information available on the use of anticancer drugs in renally impaired","volume":"10","author":"Launay-Vacher","year":"2004","journal-title":"Med Sci Monit"},{"key":"2026012223573859500_CR9","doi-asserted-by":"publisher","first-page":"e3728","DOI":"10.1097\/MD.0000000000003728","article-title":"Renal function and all-cause mortality risk among cancer patients","volume":"95","author":"Yang","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2026012223573859500_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000323740","article-title":"Chronic kidney disease in cancer patients: an independent predictor of cancer-specific mortality","volume":"33","author":"Na","year":"2011","journal-title":"Am J Nephrol"},{"key":"2026012223573859500_CR11","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/cncr.22904","article-title":"Prevalence of renal insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency of anticancer medications (IRMA) study","volume":"110","author":"Launay-Vacher","year":"2007","journal-title":"Cancer"},{"key":"2026012223573859500_CR12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/ndt\/gfw338","article-title":"Nephrotoxicity of anticancer treatment","volume":"32","author":"Malyszko","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"2026012223573859500_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.5301\/jo-n.5000006","article-title":"Immune checkpoint inhibitors in the cancer patient with an organ transplant","volume":"1","author":"Wanchoo","year":"2017","journal-title":"J Onco-Nephrol"},{"key":"2026012223573859500_CR14","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s10238-007-0145-8","article-title":"Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib","volume":"7","author":"Porta","year":"2007","journal-title":"Clin Exp Med"},{"key":"2026012223573859500_CR15","first-page":"253","article-title":"Chronic kidney disease and cancer: a troubling connection","volume":"23","author":"Stengel","year":"2010","journal-title":"J Nephrol"},{"key":"2026012223573859500_CR16","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.kint.2019.04.043","article-title":"Summary of the International conference on Onco\u2013Nephrology: an emerging field in medicine","volume":"96","author":"Capasso","year":"2019","journal-title":"Kidney Int"},{"key":"2026012223573859500_CR17"},{"key":"2026012223573859500_CR18","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.ejim.2011.05.005","article-title":"Incidence of acute kidney injury in cancer patients: a Danish population-based cohort study","volume":"22","author":"Christiansen","year":"2011","journal-title":"Eur J Intern Med"},{"key":"2026012223573859500_CR19","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/ndt\/gfv320","article-title":"Onco\u2013nephrology: a decalogue","volume":"31","author":"Cosmai","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"2026012223573859500_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/2399369318805367","article-title":"Urothelial cancer: once there were urologists, now oncologists joined, what about nephrologists?","volume":"2","author":"Cosmai","year":"2018","journal-title":"J Onco-Nephrol"},{"key":"2026012223573859500_CR21","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1681\/ASN.2015121335","article-title":"The nephrologist\u2019s tumor: basic biology and management of renal cell carcinoma","volume":"27","author":"Hu","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"2026012223573859500_CR22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nrneph.2011.168","article-title":"The pathogenesis and diagnosis of acute kidney injury in multiple myeloma","volume":"8","author":"Hutchinson","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"2026012223573859500_CR23","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/ndt\/gfy188","article-title":"Opening an onconephrology clinic: recommendations and basic requirements","volume":"33","author":"Cosmai","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2026012223573859500_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1681\/ASN.2012070690","article-title":"Onconephrology: the latest frontier in the war against kidney disease","volume":"24","author":"Salahudeen","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2026012223573859500_CR25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1136\/thoraxjnl-2014-205841","article-title":"The impact of the 'hub and spoke' model of care for lung cancer and equitable access to surgery","volume":"70","author":"Khakwani","year":"2015","journal-title":"Thorax"},{"issue":"Suppl 1","key":"2026012223573859500_CR26","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s12913-017-2341-x","article-title":"The hub-and-spoke organization design: an avenue for serving patients well","volume":"17","author":"Elrod","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"2026012223573859500_CR27","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.eururo.2014.08.075","article-title":"Defining a standard set of patient-centered outcomes for men with localized prostate cancer","volume":"67","author":"Martin","year":"2015","journal-title":"Eur Urol"},{"key":"2026012223573859500_CR28","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.ejca.2006.04.003","article-title":"EUSOMA accreditation of breast units","volume":"42","author":"Blamey","year":"2006","journal-title":"Eur J Cancer"},{"key":"2026012223573859500_CR29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ctrv.2015.11.007","article-title":"The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literature","volume":"42","author":"Pillay","year":"2016","journal-title":"Cancer Treat Rev"}],"container-title":["Journal of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00922-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40620-020-00922-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/33\/6\/1143\/66543905\/joneph_33_6_922.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40620-020-00922-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/academic.oup.com\/joneph\/article-pdf\/33\/6\/1143\/66543905\/joneph_33_6_922.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T04:57:42Z","timestamp":1769144262000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/joneph\/article\/33\/6\/1143\/8328499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,26]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,11,26]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1007\/s40620-020-00922-x","relation":{},"ISSN":["1121-8428","1724-6059"],"issn-type":[{"value":"1121-8428","type":"print"},{"value":"1724-6059","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,11,26]]},"assertion":[{"value":"26 November 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors have no conflict of interest to disclose relative to the present manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This review paper does not report any original study conducted on humans or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study, formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}